Age-related diseases have become more common with the advancing age of
the worldwide population. Such diseases involve multiple organs, with
tissue degeneration and cellular apoptosis. To date, there is a general
lack of effective drugs for treatment of most age-related diseases and
there is therefore an urgent need to identify novel drug targets for
improved treatment. Acid-sensing ion channel 1a (ASIC1a) is a
degenerin/epithelial sodium channel family member, which is activated in
an acidic environment to regulate pathophysiological processes such as
acidosis, inflammation, hypoxia, and ischemia. A large body of evidence
suggests that ASIC1a plays an important role in the development of
age-related diseases (e.g., stroke, rheumatoid arthritis, Huntington’s
disease, and Parkinson’s disease.). Herein we present: 1) a review of
ASIC1a channel properties, distribution, and physiological function; 2)
a summary of the pharmacological properties of ASIC1a; 3) and a
consideration of ASIC1a as a potential therapeutic target for treatment
of age-related disease.